Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease [NA]
This completed clinical trial compared pramipexole with levodopa in early Parkinson's disease and posted results on metabolic network activi…
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Study of the Effect of the Cognitive Orientation to Daily Occupational Performance (CO-OP) on Cognitive Impairment in Parkinson's Disease [NA]
A completed clinical trial evaluated the CO-OP cognitive intervention for cognitive impairment in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Pioglitazone in Early Parkinson's Disease [Phase 2]
Phase 2 trial of pioglitazone in early Parkinson's disease completed; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients [Phase 2]
Phase 2 safety and efficacy study of NH004 Films for relief of sialorrhea in Parkinson's disease patients completed; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease [Phase 1]
A Phase 1 study evaluating AVE8112 in Parkinson's disease was terminated; the trial assessed safety, tolerability, pharmacokinetics, and pha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease [Phase 1]
Phase 1 clinical trial update evaluating efficacy, safety and tolerability of a Pfizer-sponsored treatment in Parkinson's disease; study sta…
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease - Evolution
This clinical trial update confirms the completion of a study on orthostatic dysregulation and related gastrointestinal dysfunction in Parki…
-
CLINICAL_TRIALS trial_result · 2015-09-18Clinical Trial Update: Psychoeducational Programme for PD Patients With STN-DBS [NA]
A clinical trial update indicates the study evaluating a psychoeducational programme for Parkinson's disease patients with deep brain stimul…
-
CLINICAL_TRIALS trial_result · 2015-09-15Clinical Trial Update: Effects of Aerobic Exercise in Parkinson's Disease [NA]
A completed clinical trial studied the effects of aerobic exercise on patients with Parkinson disease; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT) [Phase 4]
Phase 4 clinical trial update for Apokyn aimed at improving morning akinesia in Parkinson's disease; status completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Motor Cortex Stimulation for Parkinson's Disease [NA]
Completed clinical trial investigating motor cortex stimulation for Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: Computer-based Cognitive Training for Parkinson Disease [NA]
The clinical trial evaluating computer-based cognitive training for Parkinson disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of Opicapone [Phase 1]
A Phase 1 study comparing two formulations of opicapone in Parkinson disease to characterize single-dose pharmacokinetics and relative bioav…
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: Effect of Rasagiline on BIA 9-1067 Pharmacokinetics [Phase 1]
Phase 1 study assessing the effect of rasagiline on the pharmacokinetics of BIA 9-1067 in Parkinson disease; results have been posted after …
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic [Phase 1]
A Phase 1 study evaluated how BIA 9-1067 affects the pharmacokinetics of Levodopa in Parkinson's disease; the trial completed and results we…
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide [Phase 1]
Phase 1 pharmacokinetic study assessing the effect of BIA 9-1067 on the PK of repaglinide in Parkinson disease; results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: Effect of BIA 9-1067 on Rasagiline Pharmacokinetics [Phase 1]
Phase 1 trial assessing whether BIA 9-1067 alters the pharmacokinetics of rasagiline in Parkinson disease; results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa [Phase 1]
Phase 1 pharmacokinetic/pharmacodynamic study evaluating the interaction between three single doses of BIA 9-1067 and a single dose of immed…
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: AFF008E: Observational Phase 1b Follow-up Extension Study for Patients With Parkinson's Disease After Immunization With AFFITOPE® PD01A
This update reports the completion of AFF008E, an observational Phase 1b follow-up extension study of Parkinson's disease patients immunized…
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease [Phase 1]
Phase 1 trial update evaluating tolerability and safety of two subcutaneous doses of AFFITOPE PD01A in early Parkinson's disease. The study …
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity [Phase 1]
Follow-up Phase 1 study evaluating a single booster of AFFITOPE PD01A for safety and clinical activity in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease
This clinical trial update summarizes the safety and efficacy findings from a completed study of long-term daily Mirapex LA use in Parkinson…
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients [Phase 3]
A Phase 3 double-blind study comparing rotigotine to placebo in early-stage idiopathic Parkinson's disease. The study results have been post…
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Rasagiline and Apathy in Parkinson's Disease [Phase 4]
A Phase 4 clinical trial evaluated rasagiline for apathy in Parkinson's disease and has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: Effect of Lower Extremity Ankle Foot Orthoses in Parkinson's Disease [NA]
The study evaluating lower-extremity ankle-foot orthoses in Parkinson's disease was terminated, and its results were posted in 2015.